Results 121 to 130 of about 25,193 (261)
Clinical Evaluation of Injectable Lorazepam as a Premedicant
Casey D. Blitt +3 more
openalex +1 more source
Participants described several challenges seeking treatment for alcohol use disorder (AUD), including multiple prior treatment attempts, delayed recognition of problematic alcohol use, and incongruent treatment expectations and experiences. Those with executive functioning challenges (53%) described the need to self‐advocate and frustration with ...
Cayley Russell +39 more
wiley +1 more source
Lorazepam for the Prevention of Recurrent Seizures Related to Alcohol [PDF]
MB Sosis
openalex +1 more source
Anxiety associated with cardiovascular disorders: A study using lorazepam
Charles M. Samet, Robert D. Geller
openalex +1 more source
ABSTRACT Background Pharmacological therapy in older persons is inherently complex due to the interplay of age‐related physiological changes, multimorbidity, and polypharmacy. These factors increase the vulnerability of elderly patients to drug interactions and adverse drug reactions.
N. N. Ngcobo
wiley +1 more source
Room F, 10/17/2000 2: 00 PM - 4: 00 PM (PS) A Double-Blind, Randomized Comparison of IV Lorazepam Vs. Midazolam for Sedation of ICU Patients Via a Pharmacologic Model [PDF]
Juliana Barr +4 more
openalex +1 more source
Aim The concomitant use of lamotrigine and valproic acid, a uridine diphosphate (UDP)‐glucuronosyltransferase inhibitor, is a known risk factor for lamotrigine‐induced rashes, which may develop into fatal or severe cutaneous adverse reactions. No drugs other than valproic acid have been shown to increase lamotrigine concentrations in humans by ...
Hiroshi Bando +21 more
wiley +1 more source
A Double-blind, Randomized Comparison of IV Lorazepam versus Midazolam for Sedation of ICU Patients via a Pharmacologic Model [PDF]
Juliana Barr +4 more
openalex +1 more source
Lorazepam or diazepam for generalised convulsions in adults [PDF]
John M. Butler
openalex +1 more source

